NCT06332677View on ClinicalTrials.gov

Target of Suv420h1/2 in Hepatocytes

NARecruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions
NAFLD
Interventions
DIAGNOSTIC_TEST

the main genes and expression by comparing the transcriptomic lipidomic profile

To identify the main genes and pathways differentially expressed and the main factors associ- ated in order to evaluate the role of SUV420H1/H2

Trial Locations (1)

20122

RECRUITING

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica, Milan

All Listed Sponsors
lead

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

OTHER